Explore News
-
New Drug Cuts Weight by 30% in Early Trials
A pioneering ‘Trojan horse’ drug uses dual hormone signals to deliver metabolic boosters directly into…
-
Next-Gen GLP-1 Drug Survodutide Shows 16% More Weight Loss Than Zepbound
A phase 3 trial reveals survodutide, a dual GLP-1 and glucagon receptor agonist, led to…
-
Why Ozempic Users Face Judgment
New research reveals a surprising social twist to weight loss medications
-
New GLP-1 Drug Shows Promise for Weight Loss
A new weight loss drug has shown promising results in a phase 3 clinical trial
-
Why Are Weight-Loss Jabs Linked to Gallbladder Issues?
Surgeons call for research into potential link between weight-loss injections and gallbladder removals
-
Hair Treatment Market Surges on GLP-1 Side Effects
Hair loss from GLP-1 weight loss drugs creates new market
-
Why Obesity Rates Are Surging in the UK
Innovative data tool to aid NHS in prioritizing weight-loss medication
-
9 in 10 Patients Report Reduced Food Noise on GLP-1s
As GLP-1 drugs silence relentless food cravings, scientists race to understand the mental chatter that…
-
New Procedure Helps Patients Keep Weight Off After Stopping Ozempic
Minimally invasive procedure shows promise in clinical trial
-
Why Retatrutide Is Being Touted as a Game-Changer
Retatrutide, an injectable peptide, shows promise in clinical trials
